The local biotechnology industry is expected to grow rapidly in the coming years, but companies need to pair up with overseas partners to ensure growth and an international presence, industry experts said yesterday.
"We expect to see more than 25 percent growth in the local biotechnology industry over the next few years," said Johnsee Lee (
PHOTO: GEORGE TSORNG, TAIPEI TIMES
In 2001, there were 750 biotechnology companies in Taiwan generating US$3 billion in revenue. In the past two years combined, private companies invested more than NT$20 billion in biotechnology enterprises, Lee said.
"The industry has become three to four times bigger than it used to be, and we are seeing many new companies setting up," Lee said.
But the key for companies to continue to grow is finding overseas partners.
"Small companies need to collaborate and build alliances internationally," he said.
One of the venture capital companies working to bring overseas and Taiwanese companies together is the Taipei-based Cheng Xin Technology Development Corp (
"Part of what we do is tying up local companies with overseas partners for licensing and technology transfers," said Adeline Wong (
To encourage more local-international pair-ups, the government planned a themed month of biotechnology events for this month. Unfortunately SARS disrupted most of the international participation, forcing the organizers to postpone two core events to the fall.
The APEC Biotechnology Conference 2003 is now scheduled to take place on Sept. 28 and Sept. 29, and BioBusiness Asia 2003 will follow directly afterwards on Sept. 30 and Oct. 1. Twenty-four foreign biotech companies have been invited to present their business models to local hopefuls at the second event, Lee said yesterday.
The Bio Taiwan exhibition will start as planned today at the World Trade Center. The event is open only to trades, with no entry fee, everyday from 10:30am to 5pm until Sunday.
"The exhibition's 500 booths are all fully booked and we are expecting 100,000 visitors, making this the largest biotechnology event in Taiwan ever," Lee said.
One focus of the exhibition will be a SARS area, featuring companies that have worked on the genomic analysis and identification of the virus, diagnostic tools to detect the virus and possible vaccines and therapeutic treatments for sufferers.
At least one investor was looking forward to the exhibition.
"This is a very good opportunity to look at the better biotechnology companies in Taiwan all at once," said Willie Lin (
But one industry watcher was disappointed by the high proportion of government involvement in the exhibition.
"Of the 500 companies exhibiting, around 200 are government bodies or research institutes," said David Silver, director of Biotech-east.com, a Web site that promotes Taiwan's biotechnology and pharmaceutical industries. "I think it's a pity there aren't more private companies, but the SARS-related area will certainly be an interesting part of the event."
The government is banking on the success of the local biotechnology industry. Last May, President Chen Shui-bian (
But making money out of biotechnology may be a gamble.
"Sadly the investments so far have not been generating as much income as we had expected," Huang said. But Lin was much more upbeat.
"So far biotechnology companies are performing well compared with international standards. We are seeing pretty good results and are satisfied," he said.
China has claimed a breakthrough in developing homegrown chipmaking equipment, an important step in overcoming US sanctions designed to thwart Beijing’s semiconductor goals. State-linked organizations are advised to use a new laser-based immersion lithography machine with a resolution of 65 nanometers or better, the Chinese Ministry of Industry and Information Technology (MIIT) said in an announcement this month. Although the note does not specify the supplier, the spec marks a significant step up from the previous most advanced indigenous equipment — developed by Shanghai Micro Electronics Equipment Group Co (SMEE, 上海微電子) — which stood at about 90 nanometers. MIIT’s claimed advances last
ISSUES: Gogoro has been struggling with ballooning losses and was recently embroiled in alleged subsidy fraud, using Chinese-made components instead of locally made parts Gogoro Inc (睿能創意), the nation’s biggest electric scooter maker, yesterday said that its chairman and CEO Horace Luke (陸學森) has resigned amid chronic losses and probes into the company’s alleged involvement in subsidy fraud. The board of directors nominated Reuntex Group (潤泰集團) general counsel Tamon Tseng (曾夢達) as the company’s new chairman, Gogoro said in a statement. Ruentex is Gogoro’s biggest stakeholder. Gogoro Taiwan general manager Henry Chiang (姜家煒) is to serve as acting CEO during the interim period, the statement said. Luke’s departure came as a bombshell yesterday. As a company founder, he has played a key role in pushing for the
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has appointed Rose Castanares, executive vice president of TSMC Arizona, as president of the subsidiary, which is responsible for carrying out massive investments by the Taiwanese tech giant in the US state, the company said in a statement yesterday. Castanares will succeed Brian Harrison as president of the Arizona subsidiary on Oct. 1 after the incumbent president steps down from the position with a transfer to the Arizona CEO office to serve as an advisor to TSMC Arizona’s chairman, the statement said. According to TSMC, Harrison is scheduled to retire on Dec. 31. Castanares joined TSMC in
EUROPE ON HOLD: Among a flurry of announcements, Intel said it would postpone new factories in Germany and Poland, but remains committed to its US expansion Intel Corp chief executive officer Pat Gelsinger has landed Amazon.com Inc’s Amazon Web Services (AWS) as a customer for the company’s manufacturing business, potentially bringing work to new plants under construction in the US and boosting his efforts to turn around the embattled chipmaker. Intel and AWS are to coinvest in a custom semiconductor for artificial intelligence computing — what is known as a fabric chip — in a “multiyear, multibillion-dollar framework,” Intel said in a statement on Monday. The work would rely on Intel’s 18A process, an advanced chipmaking technology. Intel shares rose more than 8 percent in late trading after the